Price: 63.68

Today's Change: -0.07

Today's Percent Change: -2.51%

Today's Volume: 3083002

Average Daily Volume: 6167000

52 week low: 46.01

52 week high: 66.1

Market cap: 104430000000.0

EBITDA: 6010000000.0

EBITDA / market_cap: 5.76%

Earnings per Share (EPS): 2.74

EPS / price: 4.30%

Dividend Yield: 2.42%

Dividend per share: 1.56

Book value: 8.96

Price to Book Ratio: 7.11

Price to Earnings (P/E) Ratio: 23.26

Price to Earnings Growth (PEG) Ratio: 2.1

Price to Sales (P/S) Ratio: 5.17

Short Ratio: 2.45

Exchange: "NYQ"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 54.59

Resistance: 55.23

Pivot point: 54.89

SMA 10: 55.20

SMA 50: 55.10

SMA 100: 54.80

RSI 10: 53.51

RSI 50: 50.09

RSI 100: 47.42

EMA 10: 55.11

EMA 50: 55.37

EMA 100: 54.99

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

52.33

NEGATIVE

BMY
BMY

@JacobPlieth: Updated list of failed PD-(L)1 studies $BMY $MRK $RHHBY $AZN $PFE https://t.co/2oF7uNI6Ft

@adamfeuerstein: Glioblastoma is a tough cancer to crack. Today’s failure of $ABBV ABT-414 follows similarly negative outcome of… https://t.co/MywwvHPDDe

@bs2537: RT @semodough: JEFF- ASCO: Top 15 Datasets to Watch - $BMY $CELG - updated Phase II JCAR-017 specifically in CLL ASCO: Top 15 Datasets to…

@ProVesting: $BMY $RHHBY $MRK $SYBX: Synlogic (SYBX) Enters Cancer Collaboration with Roche: https://t.co/ziWVZFr1HD

@GuillermoVela29: RT @JacobPlieth: Updated list of failed PD-(L)1 studies $BMY $MRK $RHHBY $AZN $PFE https://t.co/2oF7uNI6Ft

@semodough: JEFF- ASCO: Top 15 Datasets to Watch - $BMY $CELG - updated Phase II JCAR-017 specifically in CLL ASCO: Top 15 Dat… https://t.co/1w51AuS2l7

@TheBurdetteLawF: #estate asset watch - naked puts: names leading in volume on Thursday - $GE $QCOM $ORCL $TSLA $AMD $DIS $C $CNC $VZ… https://t.co/INg0AfEtza

@ProVesting: $BMY $NVS $RHHBY $CELG: Novartis Reports Data on Asthma Drug, Update from Annual Meet: https://t.co/0a9110wuBx

@TheBurdetteLawF: #estate asset watch - covered calls: names leading in volume Thursday - $CMCSA $KTOS $BABA $ECA $TSLA $QCOM $AAPL… https://t.co/eHxztsbPXq

@registrarjourn: Bristol-Myers Squibb Co $BMY Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/jt2lRdENhU

@EnterpriseLeade: Bristol-Myers Squibb Co $BMY Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/rkCmGVFVuB

@bulletin_en: Essex Financial Services Decreased Its Bristol Myers Squibbco $BMY Holding; Signet Jewelers Limited $SIG Had 0 Anal… https://t.co/lAdmNbPNUu

@AmericanBanking: Bristol-Myers Squibb Co $BMY Receives Consensus Rating of “Hold” from Brokerages https://t.co/cCHqF52ko6 #stocks

@bulletin_en: Jpmorgan Chase & Co $JPM Valuation Declined While Braun Stacey Associates Boosted by $639,230 Its Holding; Piedmont… https://t.co/1iMkOQ7P4w

@scapaflow1887: RT @Gabriel42869026: Cirrhosis is where there is a huge economic burden. $GALT will start P3 on patients without varices in the fall. BP ha…